• VADIMEZAN chembl:CHEMBL71263 Antineoplastic

    Alternate Names:

    ASA404
    AS-1404
    VADIMEZAN
    NSC-640488
    DMXAA
    ASA-404
    (5,6-DIMETHYL-9-OXOXANTHEN-4-YL)ACETIC ACID
    5,6-DIMETHYLXANTHENONE-4-ACETIC ACID
    5,6-DIMETHYLXANTHENONEACETIC ACID
    NSC 640488
    AS 1404
    5,6-MEXAA
    DIMETHYLOXOXANTHENE ACETIC ACID
    5,6-DIMETHYL-9-OXO-9H-XANTHENE-4-ACETIC ACID
    chembl:CHEMBL71263
    pubchem.compound:123964
    chemidplus:117570-53-3

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Types & Directionality:
    inducer (activating)

    Interaction Info:
    Notes

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Vadimezan
    Novel drug target Novel Target

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Vadimezan
    Novel drug target Established target

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Vadimezan
    Novel drug target Novel Target

    Publications:

  • Interaction Types & Directionality:
    n/a

    Interaction Info:

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class small molecule
    FDA Approval not approved

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    VADIMEZAN Primary Drug Name
    VADIMEZAN Drug Generic Name
    ASA404 Drug Synonym

    Drug Info:

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D08UOY TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: